Welcome!

Eclipse Authors: Pat Romanski, Elizabeth White, Liz McMillan, David H Deans, JP Morgenthal

Related Topics: Eclipse

Eclipse: Article

Sue Siegel Joins MDV with Focus on Life Science Investing

Brings Valuable Industry Experience Developing New Markets

MENLO PARK, Calif., March 29 /PRNewswire/ -- MDV-Mohr Davidow Ventures, (http://www.mdv.com/), a leading Silicon Valley venture capital firm, today announced the addition of Sue Siegel, a veteran life sciences executive, as a partner with the firm. She will join MDV's life sciences team and invest in cross-discipline companies developing and commercializing enabling technologies that will improve clinical research and development and transform the practice of medicine. In particular, she will partner with entrepreneurs and companies that offer solutions to modern healthcare challenges: age-onset conditions, lifestyle-induced health trends, consumer-driven wellness preservation, and healthcare economics.

"Sue is a great addition to our team," said MDV Partner Bill Ericson. "She has demonstrated exceptional company-building and leadership skills, all of which will be attractive to first-time and repeat life science entrepreneurs. She has experienced firsthand what's required to successfully bring to market enabling technologies that accelerate the healthcare industry along the path to personalized medicine."

During the past 20+ years Siegel has worked in the life sciences industry where she led businesses that commercialized key enabling technologies in biomedical research and healthcare.

"I'm pleased to be part of the MDV team." Siegel said. "It is a venture firm that is taking a leadership position in making personalized medicine more than a catch phrase. They've demonstrated their commitment by investing in promising life sciences startups looking to accelerate drug discovery, diagnostics and therapies that will more precisely help diagnose and treat diseases."

Prior to joining MDV, Siegel was President and Director of Affymetrix, Inc., a company that pioneered GeneChip(R) technology, propelling the expansion of the genomics field and the opportunity for personalized medicine. Formerly, Siegel was at Amersham International (now GE Healthcare) where her last role was President of the Hoefer-Pharmacia Biotech business. Previously, she built her experience in biotechnology and healthcare at E. I. DuPont & Co., Eastman Kodak Co., and Bio-Rad Laboratories.

Siegel is also a member of the board of directors of Pacific Biosciences, an MDV company. She is a member of the Presidents' Circle of the National Academies, serves as an advisor to the Institute of Medicine, and is a board member of The Tech Museum of Innovation, Silicon Valley. She is a member of the Advisory Council of The J. David Gladstone Institutes in San Francisco, a world leading biomedical research organization.

MDV has funded entrepreneurial life sciences teams that bring a blend of backgrounds -- from molecular biology to computer science to physics to chemistry -- and are developing companies that apply a powerful multi-disciplinary approach from inception. The firm is specifically focused on life sciences companies whose products are on track to make it to market inside of three to five years. Siegel joins Bill Ericson, Michael Goldberg, Rowan Chapman, Ph.D., and Vance Vanier, M.D., on the MDV life sciences investing team.

About MDV-Mohr Davidow Ventures MDV is a leading early stage Silicon Valley-based venture capital firm that for nearly 25 years has identified, mentored and developed entrepreneurs and young companies redefining business technology and medicine. The firm invests around three major business and science concerns: Powering the Planet; Personalizing Medicine; and Driving the Digital World. The firm partners with entrepreneurs who have deep expertise in energy and materials, life sciences, and the Internet. MDV's team engages very early in the life of a company to impact its long-term success. Category-leading companies funded by MDV include Agile, Brocade, Energy Innovations, Epigram (BRCM), FormFactor, Ipsilon Networks (NOK), Kalpana (CSCO), Nanosolar, Neuromolecular Pharmaceuticals, ONI Systems (CIEN), Pacific Biosciences, ParAllele (AFFX), Pivotal Technologies (BRCM), Proofpoint, Revenue Science, and Shutterfly. MDV has $1.4 billion dollars under management. For more information, please visit http://www.mdv.com/.

MDV-Mohr Davidow Ventures

CONTACT: Pamela Mahoney of MDV-Mohr Davidow Ventures, +1-650-854-7236,
[email protected]

Web site: http://www.mdv.com/

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Comments (0)

Share your thoughts on this story.

Add your comment
You must be signed in to add a comment. Sign-in | Register

In accordance with our Comment Policy, we encourage comments that are on topic, relevant and to-the-point. We will remove comments that include profanity, personal attacks, racial slurs, threats of violence, or other inappropriate material that violates our Terms and Conditions, and will block users who make repeated violations. We ask all readers to expect diversity of opinion and to treat one another with dignity and respect.


IoT & Smart Cities Stories
The standardization of container runtimes and images has sparked the creation of an almost overwhelming number of new open source projects that build on and otherwise work with these specifications. Of course, there's Kubernetes, which orchestrates and manages collections of containers. It was one of the first and best-known examples of projects that make containers truly useful for production use. However, more recently, the container ecosystem has truly exploded. A service mesh like Istio addr...
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-c...
Chris Matthieu is the President & CEO of Computes, inc. He brings 30 years of experience in development and launches of disruptive technologies to create new market opportunities as well as enhance enterprise product portfolios with emerging technologies. His most recent venture was Octoblu, a cross-protocol Internet of Things (IoT) mesh network platform, acquired by Citrix. Prior to co-founding Octoblu, Chris was founder of Nodester, an open-source Node.JS PaaS which was acquired by AppFog and ...
To Really Work for Enterprises, MultiCloud Adoption Requires Far Better and Inclusive Cloud Monitoring and Cost Management … But How? Overwhelmingly, even as enterprises have adopted cloud computing and are expanding to multi-cloud computing, IT leaders remain concerned about how to monitor, manage and control costs across hybrid and multi-cloud deployments. It’s clear that traditional IT monitoring and management approaches, designed after all for on-premises data centers, are falling short in ...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
Whenever a new technology hits the high points of hype, everyone starts talking about it like it will solve all their business problems. Blockchain is one of those technologies. According to Gartner's latest report on the hype cycle of emerging technologies, blockchain has just passed the peak of their hype cycle curve. If you read the news articles about it, one would think it has taken over the technology world. No disruptive technology is without its challenges and potential impediments t...
Early Bird Registration Discount Expires on August 31, 2018 Conference Registration Link ▸ HERE. Pick from all 200 sessions in all 10 tracks, plus 22 Keynotes & General Sessions! Lunch is served two days. EXPIRES AUGUST 31, 2018. Ticket prices: ($1,295-Aug 31) ($1,495-Oct 31) ($1,995-Nov 12) ($2,500-Walk-in)
IoT is rapidly becoming mainstream as more and more investments are made into the platforms and technology. As this movement continues to expand and gain momentum it creates a massive wall of noise that can be difficult to sift through. Unfortunately, this inevitably makes IoT less approachable for people to get started with and can hamper efforts to integrate this key technology into your own portfolio. There are so many connected products already in place today with many hundreds more on the h...